BENKOWITZ MICHAEL

About BENKOWITZ MICHAEL

Michael Benkowitz is the President and Chief Operating Officer of United Therapeutics Corp, a U.S.-listed biopharmaceutical company. Public company materials indicate that he joined United Therapeutics in 2011 as Executive Vice President, Organizational Development and was promoted to President and Chief Operating Officer in 2016. In his current role, he oversees a broad operational portfolio that includes commercial activities, medical affairs, and corporate compliance, as well as many of the company’s central administrative functions. He is also involved in a number of business development efforts and in the oversight of key alliances and partnerships. Benkowitz’s internal progression at United Therapeutics shows a steady move from organizational development responsibilities to enterprise-wide operational leadership. That path suggests deep familiarity with the company’s culture, operating model, and execution priorities. Recent company communications also place him in the context of United Therapeutics’ commercial momentum and revenue performance, underscoring his role in translating corporate strategy into operational results. Overall, his profile points to experience in organizational leadership, cross-functional management, business development support, and operating discipline within a highly regulated biopharmaceutical environment. The publicly available sources reviewed do not reliably identify a detailed pre-United Therapeutics career history, so it is best to avoid adding unverified prior roles or companies. As a result, the most accurate profile is one that emphasizes his long tenure at United Therapeutics, his promotion in 2016, and his current responsibility for major operating and commercial functions.